Utama › Migrain › Massachusetts
Kajian klinikal Migrain di Massachusetts
8 kajian untuk Migrain sedang mencari peserta di lokasi di Massachusetts.
Bandar di Massachusetts
Teks kajian rasmi (Bahasa Inggeris)
Study of EVO756 in Adults With Migraine
- Neurology Center of New England P.C., Foxborough
- Mass Institute of Clinical Research, Westborough
Mengambil pesertaFasa 2
Umur 18 hingga 64 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07616128Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Clinical Trials of New England, Hyde Park
Mengambil pesertaFasa 4
Umur 18 hingga 70 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT06972056A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Boston Clinical Trials - Alcanza, Boston
- MedVadis Research Corporation, LLC, Waltham
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07645924Cocoa Extract for Migraine Trial
- Brigham and Women's Hospital, Boston
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jun 2026 · NCT06808230Chiropractic Care for Episodic Migraine
- Osher Center for Integrative Health, Mass General Brigham, Boston
Mengambil peserta
Umur 18 hingga 65 · Semua jantina · Dikemas kini 26 Jun 2026 · NCT06229834BE WELL With Migraine: Brain Education and WELLness With Migraine
- Cambridge Health Alliance - Center for Mindfulness and Compassion, Cambridge
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Jun 2026 · NCT05987592Mind Body Intervention for Chronic Migraine Headaches
- Beth Israel Deaconess Medical Center, Boston
- Beth Israel Deaconess Medical Center, Boston
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Mac 2026 · NCT06690060Acceptance and Commitment Therapy to Improve Disability in Chronic Migraine
- Brigham and Women's / Faulkner Hospital, Boston
Mengambil peserta
Umur 18 hingga 65 · Semua jantina · Dikemas kini 31 Okt 2025 · NCT06795867Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.